期刊简介
《疑难病杂志》是目前国内惟一报道疑难病症的综合性医学学术期刊，由中华人民共和国卫生部主管，中国医师协会主办。本刊为“中国科技论文统计源期刊(中国科技核心期刊)”、“中国学术期刊综合评价数据库统计源期刊”、“中国生物医学核心 期刊” ，并被美国《化学文摘(CA)》、俄罗斯《文摘杂志（AJ）》、波兰《哥白尼索引(IC)》、“中国期刊全文数据库”、“中国生物医学文献数据库”、“中文生物医学期刊 文献数据库”、“中文科技期刊数据库” 等国内、外重要检索期刊和数据库收录。中国标准连续出版物号：CN 13-1316/R，ISSN 1671-6450。 本刊由著名医学家吴阶平院士担任名誉总编辑，吴咸中、陈可冀、王正国、王永炎、张运、李春岩、张伯礼、邱蔚六、郭应禄等院士担任顾问，吴以岭教授担任编委会总编辑，包括2位美籍专家在内的46名知名医学家担任编委。本刊贯彻“百花齐放、百家争鸣”的方针，开展开放式、多方位的学术交流，加速医学科技进步和发展；坚持“三个”结合，即理论与实践相结合、普及与提高相结合、现代医学与传统医学相结合，为创建具有中国特色的医学体系架桥铺路；坚持“创新”、“实用”的办刊宗旨，着力报道中医、西医、中西医结合在诊疗各种疑难病、罕少见病及各种难诊难治病症的新理论、新成果、新进展、新疗法、新药物、新经验，真正做到“引导潮流、荟萃精华、贴近临床、服务读者”。本辟有专家笔谈、论著、临床研究、络病论坛、罕少见病例、误诊误治分析、疑难病例（理）讨论、名医精粹、释疑解难、继续教育等特色栏目，本刊面向全国各级医疗、教育、研究机构的医学专业人员，是广大医务人员学术交流的园地和继续教育的良师益友。欢迎赐稿，欢迎征订。
SCI论文投稿全程模板实例
时间：2024-03-22 09:31:25
SCI论文投稿全程模板主要包括以下几个部分：投稿信（Cover Letter）、论文正文、作者信息和致谢等。下面将详细介绍这些部分，并给出实例说明。
一、投稿信（Cover Letter）
投稿信是向编辑介绍论文内容和作者情况的重要文件，也是论文投稿过程中必不可少的一部分。在投稿信中，作者需要简要介绍论文的研究背景、目的、方法、结果和结论，同时说明论文的创新性和重要性。此外，作者还需要提供自己的联系方式和作者简介等信息。
以下是一个投稿信的实例：
Dear Editor,
We are pleased to submit our manuscript entitled "XXX" for consideration for publication in your journal. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.
We believe that our study is of great interest to the readers of your journal and will contribute significantly to the field of XXX research. We have carefully checked the manuscript for typographical and grammatical errors, and have ensured that the data presented are accurate and reproducible.
Please find attached the manuscript files in Word and PDF formats, as well as the figures and tables in separate files. We have also included a list of potential reviewers for your consideration. However, we would like to note that we have no conflicts of interest with any of the reviewers listed.
Thank you for considering our manuscript for publication in your journal. We look forward to hearing from you soon.
Sincerely,
[Your Name]
[Your Affiliation]
[Your Email Address]
二、论文正文
论文正文是SCI论文投稿的核心部分，包括标题、摘要、关键词、引言、方法、结果、讨论和结论等部分。在撰写论文正文时，作者需要遵循学术规范和论文写作要求，确保论文内容准确、清晰、有条理。
以下是一个论文正文的实例（仅包含部分部分）：
Title: The effect of XXX on XXX in a mouse model of XXX
Abstract: In this study, we investigated the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.
Keywords: XXX; XXX; Mouse model; Therapeutic agent
Introduction: XXX is a common disease that affects millions of people worldwide. Current treatments for XXX are limited and often associated with side effects. Therefore, there is an urgent need to develop new therapeutic agents for the treatment of XXX. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX.
Methods: We used a mouse model of XXX to investigate the effect of XXX on XXX. Mice were randomly divided into two groups: a control group and a treatment group. The treatment group received XXX at a dose of XXX mg/kg/day for XXX days. All mice were sacrificed at the end of the experiment, and the levels of XXX were measured using XXX assay.
Results: We found that the levels of XXX were significantly reduced in the treatment group compared to the control group (Figure 1). In addition, the symptoms of XXX were also improved in the treatment group (Table 1).
Discussion: Our findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX. The reduction in the levels of XXX and improvement in the symptoms of XXX observed in our study are consistent with previous reports suggesting that XXX has anti-inflammatory and antioxidant properties. However, further studies are needed to confirm the efficacy and safety of XXX in humans.
Conclusion: In conclusion, we found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in a mouse model of XXX. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX and warrant further investigation in clinical trials.
（注：以上实例中的XXX需要根据实际情况进行替换。）
三、作者信息和致谢
在论文正文的最后，作者需要提供详细的作者信息和致谢。作者信息包括作者的姓名、单位、联系方式等；致谢则是对在论文撰写过程中给予帮助和支持的人或机构表示感谢。
以下是一个作者信息和致谢的实例：
Authors: [Your Name], [Co-author's Name], [Another Co-author's Name]
Affiliations: [Your Affiliation], [Co-author's Affiliation], [Another Co-author's Affiliation]
Contact Information: [Your Email Address], [Your Phone Number]
Acknowledgments: We would like to thank [Name of Funding Agency] for providing financial support for this study. We also thank [Name of Individual] for their assistance with data collection and analysis. Finally, we would like to express our gratitude to the anonymous reviewers for their valuable comments and suggestions on the manuscript.